0.00Open0.45Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover1136.70%IV2.78%PremiumJul 19, 2024Expiry Date0.32Intrinsic Value100Multiplier-4DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type-0.7339Delta0.6281Gamma10.40Leverage Ratio-2.4152Theta0.0000Rho-7.63Eff Leverage0.0002Vega
TELA Bio Stock Discussion
NEWS
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
TELA Bio, Inc. announces the U.S. commercial launch of OviTex IHR, a reinforced tissue matrix for inguinal hernia repair. The product offers trocar-compatibility for laparoscopic and robotic procedures, with three configurations available. OviTex has a strong clinical track record with low recurrence rates and high pati...
Beat revenue estimates and near miss on GAAP.
FDA approved surgical device
Buy this asap
No comment yet